Statera Biopharma, Inc. (STAB)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
At close: Mar 5, 2026
Statera Biopharma Market Cap
Statera Biopharma has a market cap or net worth of $7.26 thousand as of March 5, 2026. Its market cap has decreased by -50.00% in one year.
Market Cap
7.26K
Enterprise Value
n/a
Revenue
3.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 28, 2021, Statera Biopharma's market cap has decreased from 170.15M to 7.26K, a decrease of -100.00%. That is a compound annual growth rate of -88.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 7.26K | -66.67% |
| Dec 31, 2025 | 21.78K | 200.01% |
| Dec 31, 2024 | 7.26K | -83.33% |
| Dec 29, 2023 | 43.55K | -99.02% |
| Dec 30, 2022 | 4.44M | -93.99% |
| Dec 31, 2021 | 73.82M | -56.61% |
| Jul 28, 2021 | 170.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aridis Pharmaceuticals | 10.66K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Evelo Biosciences | 9.49K |
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.19K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |